Ferrous Fumarate Specifications and COA: Essential Quality Guidelines
application 2025-12-14
Ferrous Fumarate Specification and COA: Key Quality Insights
Ferrous fumarate is a widely used iron supplement known for its high bioavailability and effectiveness in treating iron deficiency anemia. Ensuring its quality requires strict adherence to specifications and a Certificate of Analysis (COA). Here’s what you need to know.
Ferrous Fumarate Specifications
Ferrous fumarate must meet pharmacopeial standards (USP, BP, or EP) to ensure purity and efficacy. Key specifications include:
– Assay (Purity): Typically ≥97.0% to ≤102.0% of C₄H₂FeO₄.
– Iron Content: ~32.9% to ensure potency.
– Heavy Metals: Limits for lead, arsenic, and mercury (e.g., ≤10 ppm lead).
– Loss on Drying (LOD): ≤1.5% to confirm low moisture content.
– Residual Solvents: Compliant with ICH guidelines (e.g., methanol ≤3000 ppm).
– Particle Size: Controlled for optimal dissolution (e.g., 90% passing 100 mesh).
Certificate of Analysis (COA) Importance
A COA is a critical document verifying that ferrous fumarate meets specifications. It includes:
1. Batch/Lot Number: Ensures traceability.
2. Test Results: Confirms compliance with assay, heavy metals, and microbiological limits.
3. Expiry Date: Guarantees stability.
4. Regulatory Compliance: References USP/EP standards.
Why Quality Matters
Substandard ferrous fumarate can compromise safety and efficacy. Always request a COA from suppliers to validate:
– Purity: Avoid contaminants affecting absorption.
– Consistency: Ensures uniform dosing in formulations.
– Regulatory Approval: Meets FDA, EMA, or other agency requirements.
Conclusion
Ferrous fumarate specifications and COA are vital for quality assurance in pharmaceuticals and supplements. Partner with certified suppliers and insist on COAs to ensure compliance and patient safety.